Form 8-K - Current report:
SEC Accession No. 0001698530-24-000119
Filing Date
2024-11-20
Accepted
2024-11-20 16:25:27
Documents
13
Period of Report
2024-11-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20241120.htm   iXBRL 8-K 22550
  Complete submission text file 0001698530-24-000119.txt   144295

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20241120.xsd EX-101.SCH 1788
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20241120_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20241120_pre.xml EX-101.PRE 12512
15 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20241120_htm.xml XML 2706
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 241480720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)